About
Technology
Issues
FAQ
Links
Official Page
Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.